Mind + Muscle

technical minds + legal muscle


dig deep

Post-Grant Proceedings Are Important For Biosimilars

  • 03.19.15
  • Paul A. Calvo, Ph.D. and Eldora L. Ellison, Ph.D.
  • IP Law360

In this IP Law360 article, Paul A. Calvo, Ph.D. and Eldora L. Ellison, Ph.D. discuss potential challenges facing biosimilar developers and the importance of post-grant patent challenges at the U.S. Patent and Trademark Office as a mechanism for obtaining early and fast patent certainty. 

To read the full article, download the attached PDF. 

Related People

Related Services

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.